INTI Insider Trading - Inhibitor Therapeutics, Inc.

Shares Outstanding	172,573,545 shares
Insider Shares	447,585,264 shares
Total Insiders	25

Insider Sentiment Score

The Insider Sentiment Score finds the companies being bought by corporate insiders.

It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of insider accumulation. The scoring model uses a combination of the net number of insiders buying the prior 90 days, the total shares bought as a percentage of float, and the total shares owned by insiders. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider accumulation.

See Highest Ranking Stocks

Officer Sentiment Score

The Officer Sentiment Score finds companies being bought by Corporate Officers.

By definition Corporate Officers are Corporate Insiders, but unlike some of the other Insiders (10% Shareholders and Board Members), Officers work for the company on a daily basis, and they user their own money when trading. (10% Shareholders and Board Members are often fund managers managing other people’s money.) As such, insider trades made by Officers are much more significant and should be treated appropriately.

Like the Insider Sentiment Score, the Officer Sentiment Score is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of officer accumulation.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider sentiment.

See Highest Ranking Stocks

Key Insider Metrics

This card shows how the company ranks along various insider metrics. The percentile rank shows how this company compares to other companies in the US markets. Higher rankings are indicative of better situations.

For example, it is generally accepted that insider buying is a positive indicator, so companies with more insider buying would rank higher than companies with less insider buying (or even insider selling).

Net Number of Insiders Buying (Rank)

0 ( )

2498 out of 11305

Net Number of Insiders Buying is the total number of insiders buying minus the total number of insiders selling in the last 90 days. The percentile rank is shown here (range from 0 to 100%).

Percent of Float Bought by Insiders (Rank)

0.000 %( )

2485 out of 11224

Percent of Float Bought by Insiders is the total number of shares purchased by insiders minus the total number of shares sold by insiders in the last 90 days, divided by the total float and multiplied by 100.

Insider Trading Chart

Inhibitor Therapeutics, Inc. insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

Insider Roster and Profitability Metrics

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.

See our leaderboard of most profitable insider traders.

Insider	Shares Owned	Split Adjusted
Black Robe Capital LLC 10% Owner - [10%]	40,202,114	40,202,114
James D Causey Director - [D]	1,000	1,000
Stefan Cross Director - [D]	0	0
Peter C Einselen	3,000
Richard J Freer Chief Executive Officer, Director, 10% Owner - [D] [O] [10%]	7,485,141	7,485,141
Hasara Garrison J. CFO and Treasurer - [O]	3,972,544	3,972,544
HedgePath, LLC 10% Owner - [10%]	79,627,069	79,627,069
Michael Allen Jerman Director - [D]	80,411	80,411

Insider	Shares Owned	Split Adjusted
Gerald P Krueger Director - [D]	0	0
Magrab E. Brendan Director - [D]	65,000	65,000
James A Mcnulty 10% Owner - [10%]	1,946,135	1,946,135
Robert Daniel Martin Director - [D]	116,000	116,000
Pharma Group Ltd Mayne 10% Owner - [10%]	204,083,227	204,083,227
Pharma Ventures Pty Ltd Mayne Director, 10% Owner - [D] [10%]	204,083,227	204,083,227
Francis E Jr Odonnell See Remarks, Director, 10% Owner - [D] [O] [10%]	85,627,069	85,627,069
Ronald E Osman Director, 10% Owner - [D] [10%]	23,554,985	23,554,985

Insider	Shares Owned	Split Adjusted
Richard Dana Ono Director - [D]	453,000	453,000
Debra Peattie	580,646
Ronald E Osman Irrevocable Trust III 10% Owner - [10%]	23,489,985	23,554,985
Samuel P Jr Sears Director - [D]	1,279,543	1,279,543
Tpb 2012 Llc 10% Owner - [10%]	28,616,250	28,616,250
Nicholas J Virca President and CEO - [O]	8,727,519	8,727,519
Niraj Vasisht	0
Watson W. Mark Director - [D]	1,054,100	1,054,100
Michelle Yanez Director - [D]	896,271	896,271

Report errors via our new Insider Auditing Tool

Track Records of Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in INTI / Inhibitor Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2019-12-12	Watson W. Mark	500	0.0619	500	0.0619	31	180	0.1035	22	72.50
2019-12-02	Hasara Garrison J.	13,500	0.0700	13,500	0.0700	945
2017-12-19	Mayne Pharma Ventures Pty Ltd	600,000	162,660.0000	600,000	162,660.0000	97,596,000,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INTI / Inhibitor Therapeutics, Inc. Insider Trades

Track Records of Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in INTI / Inhibitor Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2018-08-30	Hasara Garrison J.	100,000	0.2700	100,000	0.2700	27,000	145	0.0410	-22,900	-84.81
2017-06-30	HedgePath, LLC	2,500,000		2,500,000
2016-06-15	HedgePath, LLC	2,560,000		2,560,000
2016-06-15	ODONNELL FRANCIS E JR	2,560,000		2,560,000
2015-09-10	HedgePath, LLC	20,000,000		20,000,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

File Date	Trade Date	Form	Insider	Ticker	Security Title	Code	Direct	Exercise Price	Unit Price	Units Changed	Value Changed (1K)	Remaining Options	Remaining Shares
2025-04-10	2025-04-01	4	Vasisht Niraj	INTI	Common Stock	A - Award	D			50,000
2025-04-07	2025-04-01	4	Yanez Michelle	INTI	Common Stock	A - Award	D			50,000			896,271
2025-04-07	2025-04-01	4	SEARS SAMUEL P JR	INTI	Common Stock	A - Award	D			50,000			1,279,543
2025-04-07	2025-04-01	4	OSMAN RONALD E See Footnotes	INTI	Common Stock	A - Award	I			50,000			23,554,985
2025-04-07	2025-04-01	4	Jerman Michael Allen	INTI	Common Stock	A - Award	D			50,000			80,411
2025-02-19	2024-12-02	5	MCNULTY JAMES A	INTI	Common Stock	G - Gift	D			1,000,000			1,946,135
2025-02-19	2024-12-02	5	Yanez Michelle	INTI	Common Stock	G - Gift	D			250,000			1,146,271
2024-05-16	2024-04-01	4	Jerman Michael Allen	INTI	Common Stock	A - Award	D			50,000			80,411
2024-05-16	2024-04-01	4	OSMAN RONALD E Seefootnote	INTI	Common Stock	A - Award	I			50,000			23,564,985
2024-05-16	2024-04-01	4	SEARS SAMUEL P JR	INTI	Common Stock	A - Award	D			50,000			1,129,543
2024-05-16	2024-04-01	4	Yanez Michelle	INTI	Common Stock	A - Award	D			50,000			896,271
2023-08-29	2023-08-11	4	OSMAN RONALD E	INTI	Common Stock	A - Award	D			25,000			23,514,985
2023-08-29		3	Ronald E Osman Irrevocable Trust III	INTI	Common Stock		D						23,489,985
2023-05-22		3	Donovan James Joseph III	INTI	Common Stock		D						349,500
2023-05-22		3	Donovan James Joseph III	INTI	Common Stock		I						27,917,250
2023-05-17	2023-05-05	4	MCNULTY JAMES A	INTI	Common Stock	J - Other	I			20,101,057			26,101,057
2023-05-17	2023-05-05	4	MCNULTY JAMES A	INTI	Common Stock	J - Other	D			398,135			946,135
2023-05-17	2023-05-05	4	MCNULTY JAMES A	INTI	Common Stock	J - Other	I			-79,627,069			0
2023-05-17		3	MCNULTY JAMES A	INTI	Common Stock		D						20,101,057
2023-05-17	2023-05-05	4	Yanez Michelle	INTI	Common Stock	J - Other	D			796,271			800,673
2022-12-22		3	SEARS SAMUEL P JR	INTI	Common Stock		D						969,096
2022-12-22		3	ODONNELL FRANCIS E JR See Footnotes	INTI	Common Stock		I						85,627,069
2022-12-22		3	Yanez Michelle	INTI	Common Stock		D						4,402
2022-12-22		3	MCNULTY JAMES A See Footnotes	INTI	Common Stock		I						85,627,069
2022-12-22		3	MCNULTY JAMES A	INTI	Common Stock		D						548,000
2021-01-19	2021-01-15	4	Mayne Pharma Ventures Pty Ltd	INTI	Common Stock	J - Other	D			2,240,488			204,083,227
2020-12-28	2020-12-22	4	Watson W. Mark	INTI	Common Stock Option	A - Award	D	0.03		1,306,452		1,306,452
2020-12-28	2020-12-22	4	Martin Robert Daniel	INTI	Common Stock Option	A - Award	D	0.03		754,839		754,839
2020-12-28	2020-12-22	4	VIRCA NICHOLAS J	INTI	Common Stock Option	A - Award	D	0.03		125,000		125,000
2020-12-28	2020-12-22	4	Peattie Debra	INTI	Common Stock Option	A - Award	D	0.03		580,646		580,646
2020-12-28	2020-12-22	4	Hasara Garrison J.	INTI	Common Stock Option	A - Award	D	0.03		125,000		125,000
2020-12-28	2020-12-22	4	Ono Richard Dana	INTI	Common Stock Option	A - Award	D	0.03		754,839		754,839
2020-09-21	2020-09-17	4	VIRCA NICHOLAS J	INTI	Common Stock Option	A - Award	D	0.05		100,000		100,000
2020-09-21	2020-09-17	4	Hasara Garrison J.	INTI	Common Stock Option	A - Award	D	0.05		100,000		100,000
2020-07-20	2020-07-15	4	Mayne Pharma Ventures Pty Ltd	INTI	Common Stock	J - Other	D			3,189,688			201,842,739
2020-03-24	2020-03-20	4	Watson W. Mark	INTI	Common Stock Option	A - Award	D	0.05		1,500,000		1,500,000
2020-03-24	2020-03-20	4	Martin Robert Daniel	INTI	Common Stock Option	A - Award	D	0.05		1,000,000		1,000,000
2020-03-24	2020-03-20	4	Peattie Debra	INTI	Common Stock Option	A - Award	D	0.05		1,000,000		1,000,000
2020-03-24	2020-03-20	4	Ono Richard Dana	INTI	Common Stock Option	A - Award	D	0.05		1,000,000		1,000,000
2020-02-10	2019-12-12	5	Watson W. Mark	INTI	Common Stock	P - Purchase	D		0.0619	500	0		1,054,100
2019-12-16	2019-12-12	4	Peattie Debra	INTI	Common Stock Option	A - Award	D	0.05		210,000		210,000
2019-12-02	2019-12-02	4	Hasara Garrison J.	INTI	Common Stock	P - Purchase	D		0.0700	13,500	1		3,972,544
2019-06-10	2019-06-03	4	Watson W. Mark	HPPI	Common Stock Option	A - Award	D	0.07		25,000		25,000
2019-02-05	2019-02-03	4	MAGRAB E. BRENDAN	HPPI	Common Stock Options	A - Award	D	0.08		986,842		986,842
2019-02-05	2019-02-03	4	Watson W. Mark	HPPI	Common Stock Option	A - Award	D	0.08		657,895		657,895
2019-02-05	2019-02-03	4	Martin Robert Daniel	HPPI	Common Stock Option	A - Award	D	0.08		657,895		657,895
2019-02-05	2019-02-03	4	Ono Richard Dana	HPPI	Common Stock Option	A - Award	D	0.08		657,895		657,895
2019-01-24	2019-01-15	4	Mayne Pharma Ventures Pty Ltd	HPPI	Common Stock	J - Other	D			362,121			198,653,051
2018-12-26	2018-12-20	4	MAGRAB E. BRENDAN	HPPI	Common Stock	A - Award	D		0.0800	65,000	5		65,000
2018-12-26	2018-12-20	4	Martin Robert Daniel	HPPI	Common Stock	A - Award	D		0.0800	60,000	5		116,000
2018-12-19	2018-07-15	4	Mayne Pharma Ventures Pty Ltd	HPPI	Common Stock	J - Other	D			184,798			198,290,930
2018-08-31	2018-08-30	4	Hasara Garrison J.	HPPI	Common Stock	S - Sale	D		0.2700	-100,000	-27		3,959,044
2018-07-06	2018-07-05	4	Mayne Pharma Ventures Pty Ltd	HPPI	Series B Warrants to Purchase Common Stock	P - Purchase	D	0.28		1,739,131		1,739,131
2018-07-06	2018-07-05	4	Mayne Pharma Ventures Pty Ltd	HPPI	Series A Warrants to Purchase Common Stock	P - Purchase	D	0.23		1,739,131		1,739,131
2018-07-06	2018-07-05	4	Mayne Pharma Ventures Pty Ltd	HPPI	Series B Convertible Preferred Stock	P - Purchase	D			2,318,841		5,797,102
2018-03-15	2018-03-13	4	Martin Robert Daniel	HPPI	Common Stock Option	A - Award	D	0.27		56,000		56,000
2018-03-15	2018-03-13	4	Martin Robert Daniel	HPPI	Common Stock Option	A - Award	D	0.27		253,000		253,000
2018-03-15	2018-03-13	4	MAGRAB E. BRENDAN	HPPI	Common Stock Options	A - Award	D	0.27		345,000		345,000
2018-03-15	2018-03-13	4	Ono Richard Dana	HPPI	Common Stock Option	A - Award	D	0.27		56,000		56,000
2018-03-15	2018-03-13	4	Ono Richard Dana	HPPI	Common Stock Option	A - Award	D	0.27		253,000		253,000
2018-03-15	2018-03-13	4	VIRCA NICHOLAS J	HPPI	Common Stock Option	A - Award	D	0.27		310,000		310,000
2018-03-15	2018-03-13	4	Hasara Garrison J.	HPPI	Common Stock Option	A - Award	D	0.27		260,000		260,000
2018-03-15	2018-03-13	4	Watson W. Mark	HPPI	Common Stock Option	A - Award	D	0.27		76,000		76,000
2018-03-15	2018-03-13	4	Watson W. Mark	HPPI	Common Stock Option	A - Award	D	0.27		253,000		253,000
2018-02-12	2017-12-19	4	Cross Stefan	HPPI	Common Stock	P - Purchase	D		162,660.0000	-600,000	-97,596,000		0
2018-02-12	2017-12-19	4	Mayne Pharma Ventures Pty Ltd	HPPI	Common Stock	P - Purchase	D		162,660.0000	600,000	97,596,000		198,106,132
2018-01-11	2018-01-10	4	Mayne Pharma Ventures Pty Ltd	HPPI	Series A Warrants to Purchase Common Stock	P - Purchase	D	0.23		2,608,696		2,608,696
2018-01-11	2018-01-10	4	Mayne Pharma Ventures Pty Ltd	HPPI	Series B Warrants to Purchase Common Stock	P - Purchase	D	0.28		2,608,696		2,608,696
2018-01-11	2018-01-10	4	Mayne Pharma Ventures Pty Ltd	HPPI	Series B Convertible Preferred Stock	P - Purchase	D			3,478,261		3,478,261
2017-07-19	2017-05-04	4	MAGRAB E. BRENDAN	HPPI	Restricted Stock Units	A - Award	D			65,000		65,000
2017-07-19	2017-05-04	4	Martin Robert Daniel	HPPI	Restricted Stock Units	A - Award	D			60,000		60,000
2017-07-12	2017-06-30	4	HedgePath, LLC	HPPI	Common Stock, $.0001 par value per share	S - Sale	D			-2,500,000			79,627,069
2017-03-10	2017-03-08	4	Hasara Garrison J.	HPPI	Restricted Stock Units	M - Exercise	D			-3,500,000		0
2017-03-10	2017-03-08	4	Hasara Garrison J.	HPPI	Restricted Stock Units	M - Exercise	D			-3,500,000		0
2017-03-10	2017-03-08	4	Hasara Garrison J.	HPPI	Common Stock	F - Taxes	D		0.3400	-1,470,478	-500		4,059,044
2017-03-10	2017-03-08	4	Hasara Garrison J.	HPPI	Common Stock	F - Taxes	D		0.3400	-1,470,478	-500		4,059,044
2017-03-10	2017-03-08	4	Hasara Garrison J.	HPPI	Common Stock	M - Exercise	D			3,500,000			5,529,522
2017-03-10	2017-03-08	4	Hasara Garrison J.	HPPI	Common Stock	M - Exercise	D			3,500,000			5,529,522
2017-03-10	2017-03-08	4	Watson W. Mark	HPPI	Restricted Stock Units	M - Exercise	D			-200,000		0
2017-03-10	2017-03-08	4	Watson W. Mark	HPPI	Restricted Stock Units	M - Exercise	D			-400,000		0
2017-03-10	2017-03-08	4	Watson W. Mark	HPPI	Restricted Stock Units	M - Exercise	D			-300,000		0
2017-03-10	2017-03-08	4	Watson W. Mark	HPPI	Common Stock	F - Taxes	D		0.3400	-79,200	-27		553,600
2017-03-10	2017-03-08	4	Watson W. Mark	HPPI	Common Stock	M - Exercise	D			200,000			632,800
2017-03-10	2017-03-08	4	Watson W. Mark	HPPI	Common Stock	F - Taxes	D		0.3400	-158,400	-54		432,800
2017-03-10	2017-03-08	4	Watson W. Mark	HPPI	Common Stock	M - Exercise	D			400,000			591,200
2017-03-10	2017-03-08	4	Watson W. Mark	HPPI	Common Stock	F - Taxes	D		0.3400	-118,800	-40		191,200
2017-03-10	2017-03-08	4	Watson W. Mark	HPPI	Common Stock	M - Exercise	D			300,000			310,000
2017-03-10	2017-03-08	4	Ono Richard Dana	HPPI	Restricted Stock Units	M - Exercise	D			-150,000		0
2017-03-10	2017-03-08	4	Ono Richard Dana	HPPI	Restricted Stock Units	M - Exercise	D			-300,000		0
2017-03-10	2017-03-08	4	Ono Richard Dana	HPPI	Restricted Stock Units	M - Exercise	D			-300,000		0
2017-03-10	2017-03-08	4	Ono Richard Dana	HPPI	Common Stock	F - Taxes	D		0.3400	-59,400	-20		453,000
2017-03-10	2017-03-08	4	Ono Richard Dana	HPPI	Common Stock	M - Exercise	D			150,000			512,400
2017-03-10	2017-03-08	4	Ono Richard Dana	HPPI	Common Stock	F - Taxes	D		0.3400	-118,800	-40		362,400
2017-03-10	2017-03-08	4	Ono Richard Dana	HPPI	Common Stock	F - Taxes	D		0.3400	-118,800	-40		362,400
2017-03-10	2017-03-08	4	Ono Richard Dana	HPPI	Common Stock	M - Exercise	D			300,000			481,200
2017-03-10	2017-03-08	4	Ono Richard Dana	HPPI	Common Stock	M - Exercise	D			300,000			481,200
2017-03-10	2017-03-08	4	Cross Stefan	HPPI	Restricted Stock Units	M - Exercise	D			-300,000		0
2017-03-10	2017-03-08	4	Cross Stefan	HPPI	Restricted Stock Units	M - Exercise	D			-300,000		0
2017-03-10	2017-03-08	4	Cross Stefan	HPPI	Common Stock	M - Exercise	D			300,000			600,000
2017-03-10	2017-03-08	4	Cross Stefan	HPPI	Common Stock	M - Exercise	D			300,000			600,000
2017-03-10	2017-03-08	4	VIRCA NICHOLAS J	HPPI	Restricted Stock Units	M - Exercise	D			-15,041,738		0
2017-03-10	2017-03-08	4	VIRCA NICHOLAS J	HPPI	Common Stock	F - Taxes	D		0.3400	-6,314,219	-2,147		8,727,519
2017-03-10	2017-03-08	4	VIRCA NICHOLAS J	HPPI	Common Stock	M - Exercise	D			15,041,738			15,041,738
2016-11-15	2016-11-15	4	Mayne Pharma Ventures Pty Ltd	HPPI	Warrant to Purchase Common Stock	X - Other	D	0.12		-4,860,000		23,504,236
2016-11-15	2016-11-15	4	Mayne Pharma Ventures Pty Ltd	HPPI	Warrant to Purchase Common Stock	X - Other	D	0.08		-333		0
2016-11-15	2016-11-15	4	Mayne Pharma Ventures Pty Ltd	HPPI	Warrant to Purchase Common Stock	X - Other	D	0.09		-4,750,569		0
2016-11-15	2016-11-15	4	Mayne Pharma Ventures Pty Ltd	HPPI	Common Stock	X - Other	D			4,860,000			197,506,132
2016-11-15	2016-11-15	4	Mayne Pharma Ventures Pty Ltd	HPPI	Common Stock	X - Other	D			333			192,646,132
2016-11-15	2016-11-15	4	Mayne Pharma Ventures Pty Ltd	HPPI	Common Stock	X - Other	D			4,750,569			192,645,799
2016-11-07	2016-11-04	4	Mayne Pharma Ventures Pty Ltd	HPPI	Warrant to Purchase Common Stock	X - Other	D	0.08		-33,333,000		333
2016-11-07	2016-11-04	4	Mayne Pharma Ventures Pty Ltd	HPPI	Warrant to Purchase Common Stock	X - Other	D	0.09		-5,500,000		4,750,569
2016-11-07	2016-11-04	4	Mayne Pharma Ventures Pty Ltd	HPPI	Common Stock	X - Other	D			33,333,000			187,895,230
2016-11-07	2016-11-04	4	Mayne Pharma Ventures Pty Ltd	HPPI	Common Stock	X - Other	D			5,500,000			154,562,230
2016-07-06	2016-07-01	4	SEARS SAMUEL P JR	HPPI	Options to Purchase Common Stock	A - Award	D	0.24		150,000		150,000
2016-07-06	2016-07-01	4	SEARS SAMUEL P JR	HPPI	Restricted Stock Units	A - Award	D			150,000		150,000
2016-07-06	2016-07-01	4	Ono Richard Dana	HPPI	Restricted Stock Units	A - Award	D			150,000		150,000
2016-07-06	2016-07-01	4	Ono Richard Dana	HPPI	Options to Purchase Common Stock	A - Award	D	0.24		150,000		150,000
2016-07-06	2016-07-01	4	Watson W. Mark	HPPI	Restricted Stock Units	A - Award	D			200,000		200,000
2016-07-06	2016-07-01	4	Watson W. Mark	HPPI	Options to Purchase Common Stock	A - Award	D	0.24		200,000		200,000
2016-06-20	2016-06-15	4/A	ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC	HPPI	Common Stock, $.0001 par value per share	P - Purchase	I			2,560,000			16,560,000
2016-06-20	2016-06-15	4	HedgePath, LLC	HPPI	Common Stock, $.0001 par value per share	S - Sale	D			-2,560,000			82,127,069
2016-06-17	2016-06-15	4	ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC	HPPI	Common Stock, $.0001 par value per share	S - Sale	I			-2,560,000			11,440,000
2016-06-08	2016-06-06	4	ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC	HPPI	Common Stock, $.0001 par value per share	J - Other	I			-6,000,000			14,000,000
2016-05-27	2016-05-25	4	Mayne Pharma Group Ltd Footnote	HPPI*	Warrant to Purchase Common Stock	A - Award	I	0.01		28,364,236		71,948,138
2016-05-27	2016-05-25	4	Mayne Pharma Group Ltd Footnote	HPPI*	Common Stock	A - Award	I			27,885,000			149,062,230
2015-09-14	2015-09-10	4	ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC	HPPI	Common Stock, $.0001 par value per share	P - Purchase	I			20,000,000			20,000,000
2015-09-14	2015-09-10	4	HedgePath, LLC	HPPI	Common Stock, $.0001 par value per share	S - Sale	D			-20,000,000			84,687,069
2015-09-14	2014-08-14	4	HedgePath, LLC	HPPI	Common Stock, $.0001 par value per share	C - Conversion	D			82,156,842			104,687,069
2015-08-18	2015-08-14	4	Cross Stefan	HPPI	Restricted Stock Units	A - Award	D			300,000		300,000
2015-08-18	2015-08-14	4	Ono Richard Dana	HPPI	Restricted Stock Units	A - Award	D			300,000		300,000
2015-08-18	2015-08-14	4	SEARS SAMUEL P JR	HPPI	Restricted Stock Units	A - Award	D			300,000		300,000
2015-08-18	2015-08-14	4	Watson W. Mark	HPPI	Restricted Stock Units	A - Award	D			400,000		400,000
2015-05-19	2015-05-15	4	Mayne Pharma Group Ltd Footnote	HPPI	Warrant to Purchase Common Stock	A - Award	I	0.08		33,333,333		43,583,902
2015-05-19	2015-05-15	4	Mayne Pharma Group Ltd Footnote	HPPI	Common Stock	A - Award	I			33,333,333			121,177,230
2015-02-06	2014-07-18	5	VIRCA NICHOLAS J	HPPI	Restricted Stock Units	A - Award	D			15,041,738		15,041,738
2015-02-06	2014-08-06	5	Hasara Garrison J.	HPPI	Restricted Stock Units	A - Award	D			3,500,000		3,500,000
2015-02-06	2014-08-06	5	Hasara Garrison J.	HPPI	Restricted Stock Units	A - Award	D			3,500,000		3,500,000
2015-02-06	2014-07-18	5	Cross Stefan	HPPI	Restricted Stock Units	A - Award	D			300,000		300,000
2015-02-06	2014-07-18	5	SEARS SAMUEL P JR	HPPI	Restricted Stock Units	A - Award	D			300,000		300,000
2015-02-06	2014-07-18	5	Ono Richard Dana	HPPI	Restricted Stock Units	A - Award	D			300,000		300,000
2015-02-06	2014-07-18	5	Watson W. Mark	HPPI	Restricted Stock Units	A - Award	D			300,000		300,000
2014-09-09	2014-09-08	4	Watson W. Mark	HPPI	Common Stock	P - Purchase	D		0.1300	10,000	1		10,000
2014-07-09	2014-06-24	4	ODONNELL FRANCIS E JR By Trust	HPPI	Series A Convertible Preferred Stock	J - Other	I			18,984		64,034
2014-07-09	2014-06-24	4	ODONNELL FRANCIS E JR By Hedgepath LLC	HPPI	Series A Convertible Preferred Stock	J - Other	I			4,012		13,532
2014-07-09	2014-06-24	4	ODONNELL FRANCIS E JR By Trust	HPPI	Warrant to purchase Common Stock	J - Other	I	0.88		2,716,401		2,716,401
2014-07-09	2014-06-24	4	ODONNELL FRANCIS E JR By Hedgepath LLC	HPPI	Warrant to purchase Common Stock	J - Other	I	0.88		574,032		574,032
2014-07-09	2014-06-24	4	ODONNELL FRANCIS E JR By Trust	HPPI	Common Stock, $.0001 par value per share	J - Other	I			670,510			670,510
2014-07-09	2014-06-24	4	ODONNELL FRANCIS E JR By Hedgepath LLC	HPPI	Common Stock, $.0001 par value per share	J - Other	I			141,693			141,693
2014-07-09	2014-06-24	4	ODONNELL FRANCIS E JR By Trust	HPPI	Common Stock, $.0001 par value per share	J - Other	I		0.0750	5,300,000	398		5,970,510
2014-07-09	2014-06-24	4	ODONNELL FRANCIS E JR By Hedgepath LLC	HPPI	Common Stock, $.0001 par value per share	J - Other	I		0.0750	1,120,000	84		1,261,693
2014-07-09	2014-06-24	4	HedgePath, LLC	HPPI	Series A Convertible Preferred Stock	A - Award	D			71,636		241,637
2014-07-09	2014-06-24	4	HedgePath, LLC	HPPI	Warrant to purchase Common Stock	A - Award	D	0.88		10,250,569		10,250,569
2014-07-09	2014-06-24	4	HedgePath, LLC	HPPI	Common Stock, $.0001 par value per share	A - Award	D			2,530,227			2,530,227
2014-07-09	2014-06-24	4	HedgePath, LLC	HPPI	Common Stock, $.0001 par value per share	A - Award	D		0.0750	20,000,000	1,500		22,530,227
2014-06-26	2014-06-24	4	Mayne Pharma Ventures Pty Ltd	CBTEQ	Common Stock Purchase Warrant	A - Award	D	0.09		1		1
2014-06-26	2014-06-24	4	Mayne Pharma Ventures Pty Ltd	CBTEQ	Series A Convertible Preferred Stock	A - Award	D			258,363		258,363
2013-08-16	2013-08-13	4	ODONNELL FRANCIS E JR By Trust	CBTEQ	Series A Convertible Preferred Stock	A - Award	I			45,050		45,050
2013-08-16	2013-08-13	4	ODONNELL FRANCIS E JR By HedgePath, LLC	CBTEQ	Series A Convertible Preferred Stock	A - Award	I			9,520		9,520
2013-08-16	2013-08-13	4	HedgePath, LLC	CBTEQ	Series A Convertible Preferred Stock	A - Award	D			170,001		170,001
2013-04-19	2013-04-12	4	FREER RICHARD J	CBTEQ	Common Stock	J - Other	D		0.0457	2,846,715	130		7,485,141
2013-04-19	2013-04-12	4	SEARS SAMUEL P JR	CBTEQ	Common Stock	J - Other	D		0.0457	372,263	17		1,016,096
2012-09-07	2012-08-22	4	FREER RICHARD J	CBTEQ	Common Stock	J - Other	D		0.0200	2,025,000	40		4,638,426
2005-03-22	2005-03-22	4	CAUSEY JAMES D	CBTE	Common Stock	A - Award	D		4.2390	1,000	4		1,000
2005-01-06	2005-01-03	4	EINSELEN PETER C	CBTE	Options	A - Award	D	6.00	6.0000	3,000	18	3,000
2005-01-04	2005-01-03	4	Krueger Gerald P	CBTE	Options	A - Award	D	6.00	6.0000	3,000	18	3,000
2005-01-04	2004-11-05	4	Krueger Gerald P	CBTE	Options	A - Award	D	5.80	5.8000	5,000	29	18,000
2005-01-04	2004-11-05	4	Krueger Gerald P	CBTE	Options	A - Award	D	5.80	5.8000	5,000	29	13,000
2005-01-04	2004-11-05	4	Krueger Gerald P	CBTE	Options	A - Award	D	5.80	5.8000	5,000	29	8,000
2004-09-17		3	Krueger Gerald P	CBTE	Common Stock		D						0
2003-12-01	2003-08-08	4	CAUSEY JAMES D	CBTE	Options	A - Award	D	2.42		15,000		15,000

Open market or private purchase of non-derivative or derivative security

Open market or private sale of non-derivative or derivative security

Grant, award, or other acquisition of securities from the company (such as an option)

Conversion of derivative

Sale or transfer of securities back to the company

Payment of exercise price or tax liability using portion of securities received from the company

Gift of securities by or to the insider

Equity swaps and similar hedging transactions

Exercise or conversion of derivative security received from the company (such as an option)

A transaction voluntarily reported on Form 4

Other (accompanied by a footnote describing the transaction)

INTI / Inhibitor Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5